A Message from Prostatype Genomics AB Regarding COVID-19
In response to the COVID-19 outbreak the World Health Organization (WHO) declared a pandemic on Wednesday 11th March 2020. In this critical public health situation, Prostatype Genomics’ team extend sympathies to people who have lost their loved ones, to patients and especially healthcare professionals who are striving to give care and support.
Considering the public health preparedness efforts, our top priorities are protecting the health and safety of employees, our customers and doing what we can to support the healthcare system’s efforts around COVID-19.
Prostatype Genomics AB is prepared with internal contingencies related to COVID-19 to ensure that all the incoming patient samples for Prostatype® test will be processed and reported with the same level of quality, care and speed that is standard for us.
We are closely monitoring the situation and adjusted our operations accordingly. The Company has taken proactive measures to reduce risks for all employees and ensure business continuity. In the interim, our team is available via virtual and digital methods such as phone calls and WebEX meetings/consultations.
As always, thank you for being a Prostatype Genomics customer and for your continued trust as we manage through this difficult time together.
If you have any questions, please reach out to us:
Phone: +46 (0)8-20 87 00